Kidney News and Research

RSS

Veloxis commences LCP-Tacro Phase IIIb study in kidney transplant patients

Veloxis Pharmaceuticals A/S today announced dosing of the first patient in the STRATO (Switching kidney TRAnsplant patients with Tremor to LCP-tacrO) Phase IIIb study of LCP-Tacro in kidney transplant recipients experiencing drug-induced tremors.

4 Jan 2012

Hydrogen sulfide decreases manufacture of kidney scarring matrix proteins

Hydrogen sulfide, a gas notorious for its rotten-egg smell, may have redeeming qualities after all. It reduces high glucose-induced production of scarring proteins in kidney cells, researchers from The University of Texas Health Science Center San Antonio report in the Journal of Biological Chemistry.

4 Jan 2012

St. Michael's Hospital endocrinologist receives Novo Nordisk Diabetes Innovation Award

Dr. Andrew Advani, an endocrinologist at St. Michael's Hospital, is one of 10 researchers in North America who received a newly created Novo Nordisk Diabetes Innovation Award.

30 Dec 2011

Van Andel studies distinguish cancer subtypes and provide promising new drug targets

Two recent studies by Van Andel Research Institute scientists are providing a foundation for a more complete understanding of distinct kidney cancer subtypes, which could pave the way for better treatments.

30 Dec 2011

Avastin fails to live up to expectations for extending survival in ovarian cancer

Cancer drug Avastin has been found to add about four months to the time it takes for the cancer to worsen for women with advanced cases of ovarian cancer says a new report. However it may not extend survival significantly.

29 Dec 2011

Free, low-cost strategies to maintain good health in the new year

With the start of a new year, Dana-Farber Cancer Institute experts are encouraging people to ring in new healthy habits and offer a number of free and low-cost strategies to help people maintain good health and possibly reduce various cancer risks.

29 Dec 2011

GOG targeted therapy phase 3 clinical trial delays progression of advanced ovarian cancer

Targeted drugs, which block or disrupt particular molecules involved in the growth of tumors, have been shown to be effective treatments against many types of cancer.

29 Dec 2011

Bevacizumab delays disease progression in ovarian cancer

Treating ovarian cancer with the drug bevacizumab ("Avastin") delays the disease and may also improve survival, show the results of an international clinical trial co-led by Drs. Amit Oza of the Princess Margaret Cancer Program, University Health Network and Timothy Perren, St James's Institute of Oncology, Leeds, UK.

29 Dec 2011

Chart trends for bone and mineral metabolism in CKD

BioTrends Research Group, LLC has released findings from the 2011 ChartTrends: Bone and Mineral Metabolism in Chronic Kidney Disease report, the fifth in an on-going annual series. The study was conducted with 204 U.S. nephrologists who completed detailed chart reviews for 1,037 patients in CKD Stage 3, 4 and 5 not yet on dialysis.

29 Dec 2011

New initiative to detect cancers in earliest stages inside cells

A team of cancer imaging experts at Johns Hopkins has embarked on a five-year research initiative to speed development of early diagnostic tests and new treatments for breast, prostate and other common cancers.

29 Dec 2011

Donate Life to honor 10 deceased Hispanic organ and tissue donors with floragraphs

Almost 2,000 Hispanics donate organs every year in the United States, saving countless lives in the process, a contribution that will be recognized by the Donate Life float taking part in the 123rd Rose Parade in Pasadena. Five Hispanic men have been chosen to ride on the float as recognition for their gift of life to others through living donation or for the role they played in a deceased loved one's donation.

26 Dec 2011

FMCNA recognizes 25 dialysis patients across the nation

The nation's leading network of dialysis facilities is recognizing more than 25 patients across the nation who will be 100 years or older in 2012 and are still leading healthy, fulfilling lives without their kidney function.

26 Dec 2011

Oregon hospitals lose battle against new law; Pittsburgh hospital, insurer reach agreement

The Oregon Association of Hospitals and Health Systems lost an attempt to stop the implementation of a new law that will reduce their outpatient reimbursements by up to 50% starting January 1.

23 Dec 2011

UC San Diego surgeon removes diseased gallbladder through belly button

On Tuesday, December 20th, Santiago Horgan, MD, chief of minimally invasive surgery at UC San Diego Health System was the first surgeon in the United States to remove a diseased gallbladder through a patient's belly button with the aid of a new FDA-approved da Vinci Si Surgical System.

23 Dec 2011

Researchers discover key interaction at heart of promising new treatment for Fabry disease

A research team led by biochemist Scott Garman at the University of Massachusetts Amherst has discovered a key interaction at the heart of a promising new treatment for a rare childhood metabolic disorder known as Fabry disease.

23 Dec 2011

Correcting anemia can preserve kidney function in many transplant recipients

Correcting anemia, a red blood cell deficiency, can preserve kidney function in many kidney transplant recipients, according to a study appearing in an upcoming issue of the Journal of the American Society Nephrology.

23 Dec 2011

AUA, AIUM develop practice guideline for ultrasound imaging in urology

The American Institute of Ultrasound in Medicine (AIUM) and American Urological Association (AUA) are pleased to announce the collaborative development of the Practice Guideline for the Performance of an Ultrasound Examination in the Practice of Urology.

21 Dec 2011

CWRU receives NIDDK grant to study role of innate immunity in IBD

Investigators at Case Western Reserve University School of Medicine received a $6.75 million Program Project Grant from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) to study the role of innate immunity in inflammatory bowel disease.

21 Dec 2011

PRI now offers latest surgical robotics for patients with kidney tumors

The Porter Robotics Institute (PRI) now offers the latest in advanced surgical robotics available to patients with kidney tumors, allowing surgeons the ability to remove just a portion of the kidney.

21 Dec 2011

Eculizumab protects children from severe Shiga toxin-associated HUS

A physician and researcher at the Sainte Justine University Hospital Center (Sainte-Justine UHC), a University of Montreal affiliate, saved the life of a child and, by doing so, became the first to find a new use for a drug in the fight against deadly E. coli bacteria.

20 Dec 2011